368 related articles for article (PubMed ID: 26211948)
1. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model.
Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K
Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948
[TBL] [Abstract][Full Text] [Related]
2. Enantiomer-specific positive allosteric modulation of CB
Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
Straiker A; Mackie K
J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416
[TBL] [Abstract][Full Text] [Related]
4. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
5. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
Straiker A; Dvorakova M; Zimmowitch A; Mackie K
Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid signaling in inhibitory autaptic hippocampal neurons.
Straiker A; Mackie K
Neuroscience; 2009 Sep; 163(1):190-201. PubMed ID: 19501632
[TBL] [Abstract][Full Text] [Related]
8. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons.
Straiker A; Hu SS; Long JZ; Arnold A; Wager-Miller J; Cravatt BF; Mackie K
Mol Pharmacol; 2009 Dec; 76(6):1220-7. PubMed ID: 19767452
[TBL] [Abstract][Full Text] [Related]
9. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
Du H; Chen X; Zhang J; Chen C
Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147
[TBL] [Abstract][Full Text] [Related]
11. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
Straiker A; Mackie K
J Physiol; 2005 Dec; 569(Pt 2):501-17. PubMed ID: 16179366
[TBL] [Abstract][Full Text] [Related]
12. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
13. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
[TBL] [Abstract][Full Text] [Related]
14. Where's my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol.
Murataeva N; Dhopeshwarkar A; Yin D; Mitjavila J; Bradshaw H; Straiker A; Mackie K
Pharmacol Res; 2016 Aug; 110():173-180. PubMed ID: 27117667
[TBL] [Abstract][Full Text] [Related]
15. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
[TBL] [Abstract][Full Text] [Related]
16. CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity.
Flavin A; Azizi P; Murataeva N; Yust K; Du W; Ross R; Greig I; Nguyen T; Zhang Y; Mackie K; Straiker A
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675703
[TBL] [Abstract][Full Text] [Related]
17. PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor.
Meini S; Gado F; Stevenson LA; Digiacomo M; Saba A; Codini S; Macchia M; Pertwee RG; Bertini S; Manera C
Eur J Med Chem; 2020 Oct; 203():112606. PubMed ID: 32682199
[TBL] [Abstract][Full Text] [Related]
18. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
Bajo M; Roberto M; Schweitzer P
J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
[TBL] [Abstract][Full Text] [Related]
19. Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.
Bertini S; Chicca A; Gado F; Arena C; Nieri D; Digiacomo M; Saccomanni G; Zhao P; Abood ME; Macchia M; Gertsch J; Manera C
Bioorg Med Chem; 2017 Dec; 25(24):6427-6434. PubMed ID: 29079014
[TBL] [Abstract][Full Text] [Related]
20. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.
Di S; Boudaba C; Popescu IR; Weng FJ; Harris C; Marcheselli VL; Bazan NG; Tasker JG
J Physiol; 2005 Dec; 569(Pt 3):751-60. PubMed ID: 16239276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
